Rubella virus vaccine Pregnancy and Breastfeeding Warnings
Rubella virus vaccine is also known as: Meruvax II
Rubella virus vaccine Pregnancy Warnings
Rubella vaccine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. There is a risk of viral transmission to the fetus. Abnormalities suggestive of congenital rubella syndrome were not observed during a 10-year survey of 700 pregnant women who received rubella vaccine within 3 months before or after conception. The manufacturer's labeling states that rubella vaccination is considered contraindicated during pregnancy and that pregnancy should be avoided for 3 months following vaccination. The Advisory Committee on Immunization Practices recommends that pregnancy be avoided for 4 weeks after vaccination with the polyvalent measles/mumps/rubella vaccine, that women who become pregnant within that period be advised of the theoretical risk to the fetus, and that vaccination during pregnancy is generally not a reason to terminate the pregnancy.
Rubella virus vaccine Breastfeeding Warnings
Rubella vaccine virus may be excreted in breast milk and transmitted to nursing infants. Severe disease has not been reported in exposed infants who were serologically positive for rubella infection; however, one infant had a mild illness characteristic of acquired rubella. The manufacturer recommends that caution be used when administering rubella vaccine to breast-feeding women. The U.S. Centers for Disease Control and Prevention (CDC) consider the administration of live virus vaccines compatible with breast-feeding.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.